Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hellgren

Showing results (741-750 of 903) with videos related to

Pageof 91
Sort By:
Acta Paediatrica (Oslo, Norway : 1992)|December 28, 2017
Extreme prematurity, treated retinopathy, bronchopulmonary dysplasia and cerebral palsy are significant risk factors for ophthalmological abnormalities at 6.5 years of ageAnn Hellström, Karin Källén, Birgitta Carlsson, et al.
The British Journal of Nutrition|February 7, 2017
A study of associations between early DHA status and fatty acid desaturase (FADS) SNP and developmental outcomes in children of obese mothersKarina R Andersen, Laurine B S Harsløf, Theresia M Schnurr, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|April 16, 2021
Sphingolipidomics of serum in extremely preterm infants: Association between low sphingosine-1-phosphate levels and severe retinopathy of prematurityAnders K Nilsson, Mats X Andersson, Ulrika Sjöbom, et al.
JAMA Ophthalmology|March 25, 2016
Ophthalmologic Outcome of Extremely Preterm Infants at 6.5 Years of Age: Extremely Preterm Infants in Sweden Study (EXPRESS)Kerstin M Hellgren, Kristina Tornqvist, Peter G Jakobsson, et al.
Ambio|May 3, 2025
The great dispersal: The fall and rise of global environmental governanceSverker Sörlin, Paul Warde, Isobel Akerman, et al.
BMJ Open|May 22, 2025
Determination of prednisolone concentration in human breast milk and plasma of breastfed infants: study protocol of a Swedish multicentre low-intervention clinical trialJenny Svedenkrans, Karin Hellgren, Karin Backlund, et al.
British Journal of Pharmacology|January 22, 2017
A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preferenceSofie Gydesen, Sara Toftegaard Hjuler, Zenia Freving, et al.
Elife|October 6, 2021
AKAP79 enables calcineurin to directly suppress protein kinase A activityTimothy W Church, Parul Tewatia, Saad Hannan, et al.
Stem Cell Research|March 21, 2022
The proteome signature of cord blood plasma with high hematopoietic stem and progenitor cell countAnders K Nilsson, Halfdan Rydbeck, Annika Thorsell, et al.
International Journal of Cancer|January 13, 2023
Effects of tamoxifen on normal breast tissue histological composition: Results from a randomised six-arm placebo-controlled trial in healthy womenMarike Gabrielson, Mattias Hammarström, Magnus Bäcklund, et al.
Pageof 91

Showing results (741-750 of 903) with videos related to

Sort By:
Pageof 91
Acta Paediatrica (Oslo, Norway : 1992)|December 28, 2017
Extreme prematurity, treated retinopathy, bronchopulmonary dysplasia and cerebral palsy are significant risk factors for ophthalmological abnormalities at 6.5 years of ageAnn Hellström, Karin Källén, Birgitta Carlsson, et al.
The British Journal of Nutrition|February 7, 2017
A study of associations between early DHA status and fatty acid desaturase (FADS) SNP and developmental outcomes in children of obese mothersKarina R Andersen, Laurine B S Harsløf, Theresia M Schnurr, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|April 16, 2021
Sphingolipidomics of serum in extremely preterm infants: Association between low sphingosine-1-phosphate levels and severe retinopathy of prematurityAnders K Nilsson, Mats X Andersson, Ulrika Sjöbom, et al.
JAMA Ophthalmology|March 25, 2016
Ophthalmologic Outcome of Extremely Preterm Infants at 6.5 Years of Age: Extremely Preterm Infants in Sweden Study (EXPRESS)Kerstin M Hellgren, Kristina Tornqvist, Peter G Jakobsson, et al.
Ambio|May 3, 2025
The great dispersal: The fall and rise of global environmental governanceSverker Sörlin, Paul Warde, Isobel Akerman, et al.
BMJ Open|May 22, 2025
Determination of prednisolone concentration in human breast milk and plasma of breastfed infants: study protocol of a Swedish multicentre low-intervention clinical trialJenny Svedenkrans, Karin Hellgren, Karin Backlund, et al.
British Journal of Pharmacology|January 22, 2017
A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preferenceSofie Gydesen, Sara Toftegaard Hjuler, Zenia Freving, et al.
Elife|October 6, 2021
AKAP79 enables calcineurin to directly suppress protein kinase A activityTimothy W Church, Parul Tewatia, Saad Hannan, et al.
Stem Cell Research|March 21, 2022
The proteome signature of cord blood plasma with high hematopoietic stem and progenitor cell countAnders K Nilsson, Halfdan Rydbeck, Annika Thorsell, et al.
International Journal of Cancer|January 13, 2023
Effects of tamoxifen on normal breast tissue histological composition: Results from a randomised six-arm placebo-controlled trial in healthy womenMarike Gabrielson, Mattias Hammarström, Magnus Bäcklund, et al.
Pageof 91